The US Food and Drug Administration (FDA) announced the launch of a new framework to expedite therapies for ultra-rare diseases. The program will focus on targeted, individualized treatments for ...
Swiss multinational pharmaceutical company Novartis announced that it will build a radioligand therapy (RLT) manufacturing facility in Denton, Texas. The facility will be 46,000 square feet, joining ...
Explore the latest news and expert commentary by Melissa Nixon, brought to you by the Contributor of BioProcess International ...
Explore the latest news and expert commentary by Fiona Ford, brought to you by the Contributor of BioProcess International.
In a year dominated by onshoring stories, Aragen has seized the advantages of running a biotech business in India.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results